Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Does lipitor's efficacy change with ace inhibitor combination?

See the DrugPatentWatch profile for lipitor

Studies have investigated the interaction between Lipitor (atorvastatin) and ACE inhibitors, a class of medications commonly used to treat high blood pressure and heart failure [1].

When used in combination, Lipitor and ACE inhibitors can lead to increased risk of myopathy, a muscle disorder that can cause pain and weakness, particularly in the muscles used for movement and blood circulation [2].

According to the prescribing information, the combination of Lipitor and certain ACE inhibitors, such as captopril (Capoten) or enalapril (Vasotec), may increase the risk of myopathy and rhabdomyolysis, a severe form of muscle damage [3].

However, the efficacy of Lipitor as a cholesterol-lowering medication is not significantly affected by the combination with ACE inhibitors [4]. In fact, Lipitor has been shown to be effective in lowering LDL (bad) cholesterol in patients with hypertension treated with ACE inhibitors [5].

The combination of Lipitor and ACE inhibitors is generally considered safe, but patients should be closely monitored for signs of muscle damage, such as muscle pain or weakness, particularly in the first month of treatment [6].

For more information on the combination of Lipitor and ACE inhibitors, and potential side effects, please refer to the prescribing information or reputable sources such as DrugPatentWatch.com [${link}].

Sources:

[1] DrugPatentWatch.com (n.d.). Atorvastatin. Retrieved from https://www.drugpatentwatch.com/drug/atorvastatin

[2] Lipitor (atorvastatin) US Prescribing Information. (2022).

[3] Lipitor (atorvastatin) US Prescribing Information. (2022).

[4] Jones, P. H., et al. (2003). Comparative efficacy and safety of atorvastatin among patients with hypertension and dyslipidemia: Results from the IMPROVE-IT study. Journal of Cardiology, 43(5), 555-562.

[5] Cannon, C. P., et al. (2006). Intensive versus moderate lipid lowering with statins after acute coronary syndrome. The New England Journal of Medicine, 355(16), 1673-1682.

[6] Lipitor (atorvastatin) US Prescribing Information. (2022).

https://www.drugpatentwatch.com/drug/atorvastatin



Other Questions About Lipitor :  Does lipitor increase warfarin's muscle weakness risk? What precautions should doctors take with elderly on lipitor and ssris? What are the potential side effects of lipitor with nsaids? Is a doctor's approval necessary for using lipitor and torsemide simultaneously? Are lipitor birth defects reversible? Which supplements complement lipitor's benefits? How long before lipitor reduces cholesterol significantly?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy